- Home
- GPCR vs NAVI Comparison
GPCR vs NAVI Comparison
Compare GPCR & NAVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- NAVI
- Stock Information
- Founded
- GPCR 2016
- NAVI 1973
- Country
- GPCR United States
- NAVI United States
- Employees
- GPCR N/A
- NAVI N/A
- Industry
- GPCR
- NAVI Investment Bankers/Brokers/Service
- Sector
- GPCR
- NAVI Finance
- Exchange
- GPCR Nasdaq
- NAVI Nasdaq
- Market Cap
- GPCR 1.8B
- NAVI 1.8B
- IPO Year
- GPCR 2023
- NAVI N/A
- Fundamental
- Price
- GPCR $40.36
- NAVI $15.74
- Analyst Decision
- GPCR Buy
- NAVI Sell
- Analyst Count
- GPCR 6
- NAVI 9
- Target Price
- GPCR $81.33
- NAVI $14.67
- AVG Volume (30 Days)
- GPCR 593.8K
- NAVI 615.5K
- Earning Date
- GPCR 08-08-2024
- NAVI 10-23-2024
- Dividend Yield
- GPCR N/A
- NAVI 4.06%
- EPS Growth
- GPCR N/A
- NAVI N/A
- EPS
- GPCR N/A
- NAVI 1.38
- Revenue
- GPCR N/A
- NAVI $1,032,000,000.00
- Revenue This Year
- GPCR N/A
- NAVI N/A
- Revenue Next Year
- GPCR N/A
- NAVI N/A
- P/E Ratio
- GPCR N/A
- NAVI $11.44
- Revenue Growth
- GPCR N/A
- NAVI N/A
- 52 Week Low
- GPCR $26.61
- NAVI $13.96
- 52 Week High
- GPCR $75.02
- NAVI $19.68
- Technical
- Relative Strength Index (RSI)
- GPCR 57.92
- NAVI 53.55
- Support Level
- GPCR $38.27
- NAVI $14.36
- Resistance Level
- GPCR $42.67
- NAVI $16.02
- Average True Range (ATR)
- GPCR 2.29
- NAVI 0.50
- MACD
- GPCR 0.31
- NAVI -0.07
- Stochastic Oscillator
- GPCR 76.72
- NAVI 57.58
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.
About NAVI Navient Corporation
Navient Corp provides technology-enabled education finance and business processing solutions that simplify complex programs and help millions of people achieve success. It operates business in three segments: Federal Education Loans, Consumer Lending and Business Processing.